Concepedia

Carina Bleickardt

CB

Statistics

Publications

12

Citations

367

H-Index

12

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Carina Bleickardt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in neuropharmacology, pharmacology, and medicine.

Publications per year

2008–2014

12

Publications

12

Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior

Carina Bleickardt, Deborra Mullins, Cliona MacSweeney et al. · Psychopharmacology · 2008 · 72 citations

, , +16

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

Shu‐Wei Yang, Jennifer Smotryski, William T. McElroy et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

, , +9

Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors

Samantha Côté, Vineet C. Chitravanshi, Carina Bleickardt et al. · Behavioural Brain Research · 2014 · 36 citations

, , +12

The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia

Ginny D. Ho, Shu‐Wei Yang, Jennifer Smotryski et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 33 citations · Full text

, , +6

Pyrazoloquinolines as PDE10A inhibitors: Discovery of a tool compound

William T. McElroy, Zheng Tan, Kallol Basu et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 31 citations · Full text

, , +11

1–5 of 12